Legend Biotech CorporationLEGNNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank88
3Y CAGR+6.8%
5Y CAGR+6.2%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+6.8%/yr
Quarterly compound
5Y CAGR
+6.2%/yr
Consistent
Percentile
P88
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 68.35% |
| Q2 2025 | -24.24% |
| Q1 2025 | -483.94% |
| Q4 2024 | 120.97% |
| Q3 2024 | -588.73% |
| Q2 2024 | 69.57% |
| Q1 2024 | 58.71% |
| Q4 2023 | -132.80% |
| Q3 2023 | 68.76% |
| Q2 2023 | -77.63% |
| Q1 2023 | 17.50% |
| Q4 2022 | -59.94% |
| Q3 2022 | 56.03% |
| Q2 2022 | -370.29% |
| Q1 2022 | 53.49% |
| Q4 2021 | 29.55% |
| Q3 2021 | -36.91% |
| Q2 2021 | -13.21% |
| Q1 2021 | -39.90% |
| Q4 2020 | 13.10% |
| Q3 2020 | 50.66% |
| Q2 2020 | -204.96% |
| Q1 2020 | 30.83% |
| Q4 2019 | -130.04% |
| Q3 2019 | 3.49% |
| Q2 2019 | -131.71% |
| Q1 2019 | 0.00% |